Niki BioSolutions, Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Niki BioSolutions, Inc. (NIKI) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $338.52 thousand for the 12-month period ending 2023-12-31, per its 6-K filed 2025-10-08.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2025-10-08
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|
| 2023-12-31 | $338.52K 6-K · filed 2025-10-08 | |
| 2023-06-30 | $338.52K 6-K · filed 2024-12-20 | |
| 2022-12-31 | $549.60K 6-K · filed 2025-10-08 | |
| 2020-12-31 | $1.11M 20-F/A · filed 2023-01-17 | |
| 2020-06-30 | $1.09M 6-K · filed 2021-09-15 |